Myotonia congenita in a Greek cohort: Genotype spectrum and impact of the CLCN1:c.501C > G variant as a genetic modifier.

MLA

Marinakis, Nikolaos M., et al. “Myotonia Congenita in a Greek Cohort: Genotype Spectrum and Impact of the CLCN1:C.501C > G Variant as a Genetic Modifier.” Muscle & Nerve, vol. 70, no. 2, Aug. 2024, pp. 240–47. EBSCOhost, https://doi.org/10.1002/mus.28180.

APA

Marinakis, N. M., Svingou, M., Papadimas, G.-K., Papadopoulos, C., Chroni, E., Pons, R., Pavlou, E., Sarmas, I., Kosma, K., Apostolou, P., Sofocleous, C., Traeger-Synodinos, J., & Kekou, K. (2024). Myotonia congenita in a Greek cohort: Genotype spectrum and impact of the CLCN1:c.501C > G variant as a genetic modifier. Muscle & Nerve, 70(2), 240–247. https://doi.org/10.1002/mus.28180

Chicago

Marinakis, Nikolaos M, Maria Svingou, Giorgos-Konstantinos Papadimas, Constantinos Papadopoulos, Elisabeth Chroni, Roser Pons, Evangelos Pavlou, et al. 2024. “Myotonia Congenita in a Greek Cohort: Genotype Spectrum and Impact of the CLCN1:C.501C > G Variant as a Genetic Modifier.” Muscle & Nerve 70 (2): 240–47. doi:10.1002/mus.28180.